/
/
/

Anuh Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012Jun 2012Mar 2012Dec 2011Sep 2011Jun 2011Mar 2011Dec 2010Sep 2010Jun 2010Mar 2010Dec 2009Sep 2009Jun 2009Mar 2009Dec 2008Sep 2008Jun 2008Mar 2008Dec 2007Sep 2007Jun 2007Mar 2007Dec 2006Sep 2006Jun 2006Mar 2006Dec 2005Sep 2005Jun 2005Mar 2005
₹194 Cr₹202 Cr₹197 Cr₹186 Cr₹186 Cr₹198 Cr₹160 Cr₹166 Cr₹138 Cr₹164 Cr₹172 Cr₹150 Cr₹161 Cr₹157 Cr₹139 Cr₹115 Cr₹116 Cr₹129 Cr₹132 Cr₹109 Cr₹117 Cr₹97 Cr₹98 Cr₹112 Cr₹124 Cr₹72 Cr₹76 Cr₹74 Cr₹85 Cr₹83 Cr₹70 Cr₹87 Cr₹80 Cr₹67 Cr₹63 Cr₹55 Cr₹55 Cr₹57 Cr₹57 Cr₹50 Cr₹49 Cr₹73 Cr₹78 Cr₹91 Cr₹87 Cr₹71 Cr₹66 Cr₹71 Cr₹75 Cr₹77 Cr₹67 Cr₹67 Cr₹56 Cr₹59 Cr₹66 Cr₹52 Cr₹66 Cr₹48 Cr₹66 Cr₹60 Cr₹51 Cr₹40 Cr₹46 Cr₹51 Cr₹38 Cr₹45 Cr₹46 Cr₹36 Cr₹38 Cr₹27 Cr₹26 Cr₹35 Cr₹33 Cr₹32 Cr₹27 Cr₹28 Cr₹24 Cr₹24 Cr₹17 Cr₹19 Cr₹22 Cr₹24 Cr₹19 Cr₹20 Cr₹14 Cr₹12 Cr
₹3 Cr-₹1 Cr₹4 Cr₹98 L₹3 Cr₹1 Cr₹94 L₹3 Cr₹4 Cr₹3 Cr₹4 Cr₹2 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹96 L₹1 Cr₹34 L₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹1 Cr₹1 Cr₹83 L₹1 Cr₹84 L₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹62 L₹53 L₹1 Cr₹1 Cr₹1 Cr₹71 L₹1 Cr₹2 Cr₹1 Cr₹93 L₹1 Cr₹1 Cr₹42 L₹1 Cr₹43 L₹2 Cr₹38 L₹99 L₹1 Cr₹1 Cr₹73 L₹2 Cr₹76 L₹2 Cr₹1 Cr₹4 Cr₹92 L-₹40 L-₹57 L-₹3 Cr₹19 L₹45 L₹1 Cr₹54 L₹72 L₹95 L₹78 L₹45 L₹5 L₹49 L₹85 L₹1 Cr₹24 L₹45 L
₹197 Cr₹201 Cr₹201 Cr₹187 Cr₹190 Cr₹200 Cr₹160 Cr₹169 Cr₹142 Cr₹167 Cr₹176 Cr₹152 Cr₹165 Cr₹158 Cr₹141 Cr₹117 Cr₹117 Cr₹130 Cr₹132 Cr₹111 Cr₹119 Cr₹99 Cr₹101 Cr₹116 Cr₹127 Cr₹73 Cr₹77 Cr₹75 Cr₹86 Cr₹84 Cr₹71 Cr₹89 Cr₹81 Cr₹69 Cr₹65 Cr₹58 Cr₹58 Cr₹59 Cr₹58 Cr₹51 Cr₹50 Cr₹75 Cr₹79 Cr₹92 Cr₹88 Cr₹72 Cr₹68 Cr₹72 Cr₹77 Cr₹78 Cr₹68 Cr₹68 Cr₹57 Cr₹60 Cr₹66 Cr₹54 Cr₹66 Cr₹51 Cr₹67 Cr₹61 Cr₹52 Cr₹41 Cr₹47 Cr₹53 Cr₹39 Cr₹47 Cr₹47 Cr₹40 Cr₹39 Cr₹26 Cr₹26 Cr₹33 Cr₹33 Cr₹33 Cr₹28 Cr₹29 Cr₹25 Cr₹25 Cr₹18 Cr₹20 Cr₹22 Cr₹25 Cr₹20 Cr₹21 Cr₹15 Cr₹13 Cr
₹180 Cr₹185 Cr₹183 Cr₹177 Cr₹179 Cr₹182 Cr₹147 Cr₹151 Cr₹129 Cr₹147 Cr₹150 Cr₹134 Cr₹150 Cr₹145 Cr₹129 Cr₹104 Cr₹108 Cr₹118 Cr₹123 Cr₹99 Cr₹112 Cr₹97 Cr₹96 Cr₹105 Cr₹105 Cr₹74 Cr₹68 Cr₹71 Cr₹78 Cr₹76 Cr₹64 Cr₹79 Cr₹74 Cr₹64 Cr₹58 Cr₹54 Cr₹51 Cr₹52 Cr₹52 Cr₹44 Cr₹45 Cr₹68 Cr₹71 Cr₹80 Cr₹76 Cr₹66 Cr₹59 Cr₹65 Cr₹67 Cr₹70 Cr₹62 Cr₹62 Cr₹52 Cr₹56 Cr₹63 Cr₹49 Cr₹61 Cr₹46 Cr₹62 Cr₹56 Cr₹47 Cr₹37 Cr₹43 Cr₹47 Cr₹35 Cr₹43 Cr₹44 Cr₹33 Cr₹34 Cr₹24 Cr₹22 Cr₹29 Cr₹27 Cr₹30 Cr₹24 Cr₹25 Cr₹23 Cr₹22 Cr₹15 Cr₹18 Cr₹19 Cr₹23 Cr₹16 Cr₹17 Cr₹13 Cr₹11 Cr
₹19 Cr₹19 Cr₹21 Cr₹13 Cr₹14 Cr₹20 Cr₹16 Cr₹20 Cr₹14 Cr₹22 Cr₹28 Cr₹20 Cr₹17 Cr₹15 Cr₹15 Cr₹15 Cr₹12 Cr₹15 Cr₹12 Cr₹14 Cr₹10 Cr₹6 Cr₹9 Cr₹14 Cr₹26 Cr₹3 Cr₹10 Cr₹5 Cr₹9 Cr₹9 Cr₹8 Cr₹10 Cr₹8 Cr₹5 Cr₹7 Cr₹5 Cr₹8 Cr₹8 Cr₹6 Cr₹7 Cr₹6 Cr₹8 Cr₹8 Cr₹12 Cr₹12 Cr₹9 Cr₹9 Cr₹8 Cr₹10 Cr₹9 Cr₹7 Cr₹7 Cr₹5 Cr₹5 Cr₹3 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹6 Cr₹4 Cr₹4 Cr₹4 Cr₹7 Cr₹5 Cr₹2 Cr₹4 Cr₹4 Cr₹6 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹4 Cr₹1 Cr₹2 Cr
₹30,000₹11 L₹8 L₹8 L₹21 L₹3 L₹28 L₹16 L₹14 L₹10 L₹14 L₹9 L₹2 L₹2 L₹3 L₹11 L₹6 L-₹18 L₹58 L₹39 L₹18 L₹15 L₹42 L₹48 L₹45 L₹55 L₹11 L₹6 L₹8 L₹7 L₹8 L₹2 L₹80,000₹4 L₹30,000₹10,000₹0₹3 L₹40,000₹80,000₹30,000₹3 L₹1 L₹20,000₹10,000₹3 L₹1 L₹30,000₹70,000₹6 L₹2 L₹2 L₹40,000₹1 L₹1 L₹1 L₹90,000₹33 L₹1 L₹60,000₹4 L₹3 L₹7 L₹2 L₹40,000₹4 L₹70,000₹4 L₹3 L₹19 L₹36 L₹21 L₹8 L₹5 L₹5 L₹9 L₹2 L₹3 L₹90,000-₹70,000₹90,000₹50,000₹1 L₹70,000₹30,000₹70,000
₹17 Cr₹16 Cr₹18 Cr₹10 Cr₹11 Cr₹17 Cr₹13 Cr₹18 Cr₹12 Cr₹20 Cr₹25 Cr₹18 Cr₹15 Cr₹13 Cr₹12 Cr₹13 Cr₹10 Cr₹12 Cr₹9 Cr₹11 Cr₹7 Cr₹2 Cr₹5 Cr₹10 Cr₹22 Cr-₹2 Cr₹8 Cr₹4 Cr₹8 Cr₹8 Cr₹7 Cr₹10 Cr₹8 Cr₹5 Cr₹7 Cr₹4 Cr₹8 Cr₹8 Cr₹6 Cr₹7 Cr₹5 Cr₹7 Cr₹8 Cr₹12 Cr₹12 Cr₹7 Cr₹9 Cr₹7 Cr₹9 Cr₹9 Cr₹6 Cr₹6 Cr₹5 Cr₹4 Cr₹3 Cr₹5 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹6 Cr₹4 Cr₹4 Cr₹3 Cr₹7 Cr₹4 Cr₹2 Cr₹3 Cr₹4 Cr₹6 Cr₹3 Cr₹4 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹1 Cr₹2 Cr
₹11 Cr₹12 Cr₹13 Cr₹8 Cr₹8 Cr₹12 Cr₹10 Cr₹15 Cr₹10 Cr₹15 Cr₹19 Cr₹14 Cr₹12 Cr₹10 Cr₹9 Cr₹10 Cr₹7 Cr₹9 Cr₹7 Cr₹9 Cr₹6 Cr₹90 L₹4 Cr₹7 Cr₹17 Cr-₹92 L₹6 Cr₹3 Cr₹6 Cr₹5 Cr₹5 Cr₹7 Cr₹6 Cr₹3 Cr₹5 Cr₹2 Cr₹6 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹7 Cr₹8 Cr₹5 Cr₹6 Cr₹5 Cr₹7 Cr₹6 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹5 Cr₹3 Cr₹98 L₹3 Cr₹3 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr₹3 Cr₹69 L₹100 L

Share Price Live Stats

Open (₹)80.75
Volume (₹)80,373.00
High (₹)82.35
Upper Circuit95.61
Low (₹)79.70
Lower Circuit63.75
Prev Close79.68
52W High (₹)93.00
Price80.73
52W Low (₹)67.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)797.68 Cr
Div. Yield (%)1.88
PE Ratio18.06
Debt to Equity0.00
Price to Book1.91
Book Value35.14
EPS (TTM)4.41
Face Value5.00
ROE (%)12.10

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ANUHPHRNSE
LTP
1W Low
1W High
Market cap (₹)
1899-21 (-1.09%)
1895
1984.80
4,56,833Cr
9100-139 (-1.50%)
9087
9467
2,45,426Cr
4857-193 (-3.82%)
4823
5066
1,87,320Cr
1120-71 (-5.96%)
1120
1187
1,13,217Cr
1385-38.5 (-2.70%)
1375.50
1426.10
1,12,212Cr
1840-98.5 (-5.08%)
1811.70
1949
1,01,155Cr
2110-61.5 (-2.83%)
2100.60
2192
97,626Cr
2327.9-55 (-2.31%)
2317
2419.20
96,859Cr
1151-27 (-2.29%)
1151
1179.90
96,406Cr
1653.1+7.8 (0.47%)
1622.60
1717
93,614Cr
80.73-2.84 (-3.40%)
78.10
83.90
798Cr

Key Highlights of Anuh Pharma Ltd’s P&L

In 2026-03-31, Anuh Pharma Ltd reported total revenue of ₹771.66Cr, compared with ₹661.51Cr in 2025-03-31, reflecting Anuh Pharma Ltd turnover.

Depreciation was ₹11.38Cr and finance costs were ₹95.5Lakh in 2026-03-31

Profit Before Tax (PBT) has been ₹54.22Cr in 2026-03-31 as compared to ₹61.01Cr in 2025-03-31.

Net Profit (PAT) was ₹41.05Cr in 2026-03-31 compared with ₹47.35Cr in 2025-03-31.

Earnings per share (EPS) were ₹4.10 in 2026-03-31, compared with ₹9.45 in 2025-03-31.